OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
January 02, 2020
FDA’s approval rate slowed, but the US agency is still ahead of its international counterparts in green-lighting new drugs for market.
December 02, 2019
The key is to ensure that excipients only interact with APIs via desired mechanisms.
November 06, 2019
Using automation and taking a step-by-step approach can facilitate the process of selecting a top-quality cell-line source.
November 02, 2019
Several factors must be considered when reformulating APIs for pediatric, geriatric, and other specialty patient populations.
October 02, 2019
Limited guidance and numerous challenges create confusion about the scope and timing of stability testing for drugs in development.
September 02, 2019
Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies.